TY - JOUR
T1 - Cellular Plasticity Confers Migratory and Invasive Advantages to a Population of Glioblastoma-Initiating Cells that Infiltrate Peritumoral Tissue
AU - Ruiz-Ontanon, Patricia
AU - Orgaz, Jose L.
AU - Aldaz, Beatriz
AU - Elosegui-Artola, Alberto
AU - Martino, Juan
AU - Berciano, Maria T.
AU - Montero, Juan A.
AU - Grande, Lara
AU - Nogueira, Lorena
AU - Diaz-Moralli, Santiago
AU - Esparis-Ogando, Azucena
AU - Vazquez-Barquero, Alfonso
AU - Lafarga, Miguel
AU - Pandiella, Atanasio
AU - Cascante, Marta
AU - Segura, Victor
AU - Martinez-Climent, Jose A.
AU - Sanz Moreno, Vicky
AU - Fernandez-Luna, Jose L.
PY - 2013/6
Y1 - 2013/6
N2 - Glioblastoma (GBM) is associated with infiltration of peritumoral (PT) parenchyma by isolated tumor cells that leads to tumor regrowth. Recently, GBM stem-like or initiating cells (GICs) have been identified in the PT area, but whether these GICs have enhanced migratory and invasive capabilities compared with GICs from the tumor mass (TM) is presently unknown. We isolated GICs from the infiltrated PT tissue and the TM of three patients and found that PT cells have an advantage over TM cells in two-dimensional and three-dimensional migration and invasion assays. Interestingly, PT cells display a high plasticity in protrusion formation and cell shape and their migration is insensitive to substrate stiffness, which represent advantages to infiltrate microenvironments of different rigidity. Furthermore, mouse and chicken embryo xenografts revealed that only PT cells showed a dispersed distribution pattern, closely associated to blood vessels. Consistent with cellular plasticity, simultaneous Rac and RhoA activation are required for the enhanced invasive capacity of PT cells. Moreover, Rho GTPase signaling modulators alpha V beta 3 and p27 play key roles in GIC invasiveness. Of note, p27 is upregulated in TM cells and inhibits RhoA activity. Gene silencing of p27 increased the invasive capacity of TM GICs. Additionally, beta 3 integrin is upregulated in PT cells. Blockade of dimeric integrin alpha V beta 3, a Rac activator, reduced the invasive capacity of PT GICs in vitro and abrogated the spreading of PT cells into chicken embryos. Thus, our results describe the invasive features acquired by a unique subpopulation of GICs that infiltrate neighboring tissue.
AB - Glioblastoma (GBM) is associated with infiltration of peritumoral (PT) parenchyma by isolated tumor cells that leads to tumor regrowth. Recently, GBM stem-like or initiating cells (GICs) have been identified in the PT area, but whether these GICs have enhanced migratory and invasive capabilities compared with GICs from the tumor mass (TM) is presently unknown. We isolated GICs from the infiltrated PT tissue and the TM of three patients and found that PT cells have an advantage over TM cells in two-dimensional and three-dimensional migration and invasion assays. Interestingly, PT cells display a high plasticity in protrusion formation and cell shape and their migration is insensitive to substrate stiffness, which represent advantages to infiltrate microenvironments of different rigidity. Furthermore, mouse and chicken embryo xenografts revealed that only PT cells showed a dispersed distribution pattern, closely associated to blood vessels. Consistent with cellular plasticity, simultaneous Rac and RhoA activation are required for the enhanced invasive capacity of PT cells. Moreover, Rho GTPase signaling modulators alpha V beta 3 and p27 play key roles in GIC invasiveness. Of note, p27 is upregulated in TM cells and inhibits RhoA activity. Gene silencing of p27 increased the invasive capacity of TM GICs. Additionally, beta 3 integrin is upregulated in PT cells. Blockade of dimeric integrin alpha V beta 3, a Rac activator, reduced the invasive capacity of PT GICs in vitro and abrogated the spreading of PT cells into chicken embryos. Thus, our results describe the invasive features acquired by a unique subpopulation of GICs that infiltrate neighboring tissue.
KW - Glioblastoma-initiating cells
KW - Invasion
KW - Integrin alpha V beta 3
KW - IN-VIVO
KW - EXTRACELLULAR-MATRIX
KW - GROWTH
KW - ACTIVATION
KW - MOTILITY
KW - GLIOMA
KW - EXPRESSION
KW - INTEGRINS
KW - PROTEIN
KW - GTPASES
U2 - 10.1002/stem.1349
DO - 10.1002/stem.1349
M3 - Article
SN - 1066-5099
VL - 31
SP - 1075
EP - 1085
JO - Stem Cells
JF - Stem Cells
IS - 6
M1 - N/A
ER -